FSMB | Online Prescriber Education Network (OPEN) | Continuing Medical Education (CME) Modules

Home

About Us

LICENSURE EXAMINATIONS (USMLE/PLAS/SPEX)

CREDENTIALS VERIFICATION (FCVS)

LICENSURE APPLICATION
(UA)

PHYSICIAN DATA (FPDC)

EDUCATION & MEETINGS

ADVOCACY & POLICY

FSMB FOUNDATION

PUBLICATIONS & MEDIA

CONTACT A STATE MEDICAL BOARD

CERTIFICATIONS

ONLINE PRESCRIBER EDUCATION NETWORK (OPEN)

Continuing Medical Education (CME) Modules
Recipients of the Attorney General Consumer and Prescriber Education Program grants are developing Web-based, accredited courses to educate health care professionals about pharmaceutical industry marketing techniques and their effect on prescribing practices. Most courses are available free of charge to licensed medical prescribers in the nation and some may be taken for continuing medical education credit.**

Accredited CME modules will be added to the OPEN portal as they are completed. The following are currently available:

Course	Maximum CME Credit	Expiration	Institution / Organization	Information
Off-Label Use of Pharmaceuticals	1.00	11/30/2010	Kaiser Foundation Health Plan of Colorado	information
Accessing and Appraising Unbiased Drug Information	2.00	11/30/2010	Kaiser Foundation Health Plan of Colorado	information
Addressing Patient Inquiries about Specific Medications Advertised Directly to Consumers	1.00	11/30/2010	Kaiser Foundation Health Plan of Colorado	information
Optimal Prescribing	3.00	6/30/2011	Lovelace Clinic Foundation	information
Evidence Based Medicine (EBM)	.75	12/31/2011	Meyers Primary Care Institute	information
Provider-Pharmaceutical Representative (PR) Communication (accredited for medical ethics and/or professional responsibility)	.75	12/31/2011	Meyers Primary Care Institute	information
Communicating with Patients (accredited for medical ethics and/or professional responsibility)	.75	12/31/2011	Meyers Primary Care Institute	information
Organizational Influences on Prescribing (accredited for medical ethics and/or professional responsibility)	.50	12/31/2011	Meyers Primary Care Institute	information
Pharmaceutical Development and Regulation	.50	10/21/2010	Meyers Primary Care Institute	information
Pharmaceutical Marketing (accredited for medical ethics and/or professional responsibility)	.75	12/31/2010	Meyers Primary Care Institute	information
Why and how are drugs approved?	0	n/a	MGH Institute of Health Professions (peRX Project)	information
There's no such thing as a free lunch.. or dinner	0	n/a	MGH Institute of Health Professions (peRX Project)	information
Is this the right thing to do?	0	n/a	MGH Institute of Health Professions (peRX Project)	information
How can I improve my practice?	0	n/a	MGH Institute of Health Professions (peRX Project)	information
What's Hype? What's Right? Assessing New Information from Pharm Reps to the Latest Journals	2.00	1/1/2011	Northeastern Ohio University College of Medicine and Pharmacy (NEOUCOM)	information
Information Mastery Practicum: How to Select and Use the Best Hunting and Foraging Tools	2.50	6/6/2011	Northeastern Ohio University College of Medicine and Pharmacy (NEOUCOM)	information
Using Evidence to Guide Drug Therapy Decisions	1.50	1/31/2012	Oregon Office for Health Policy and Research	information
Critical Appraisal: Randomized-Controlled Trials for Drug Therapy	1.00	1/31/2012	Oregon Office for Health Policy and Research	information
Critical Appraisal: Systematic Reviews and Clinical Practice Guidelines for Drug Therapy	1.25	1/31/2012	Oregon Office for Health Policy and Research	information
Pharmaceutical Industry Marketing and Influence	1.50	1/31/2012	Oregon Office for Health Policy and Research	information
Recognizing Pharmaceutical Industry Conflicts of Interest	1.50	1/31/2011	Oregon Office for Health Policy and Research	information
Drug Approval in the U.S.: How Drugs Get to Market	1.00	3/13/2011	PharmedOut (Georgetown University Medical Center)	information
Generic Drugs: Prescribing Sensibly	1.00	3/13/2011	PharmedOut (Georgetown University Medical Center)	information
Pharmalyzer: Are you prescribing under the influence?	3.00	3/30/2012	PharmedOut (Georgetown University Medical Center)	information
Marketing of Medicines	2.50	1/1/2012	University of California, San Francisco	information
Introduction of FLIP Project and Neurontin® Case	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Drug Formularies: Hassles, Restrictions, and Switches... or Drugs of Choice?	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
False and Misleading Pharmaceutical Advertising and Promotion	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Impact of Drug Industry Promotional Activity on Prescriber	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Drug Appropriateness Criteria: Potential for Indication Creep	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Analyzing Medication Trials: Tricks to Avoid Being Tricked	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Analyzing Statistical Analysis in Trials: Don't Get Lied to by Statistics	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Surrogate Endpoints	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Comparative Effectiveness	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Alternative Information Sources	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Principles of Conservative Prescribing	.50	3/31/2011	University of Illinois at Chicago College of Pharmacy and College of Medicine	information
Pharmacologic Management of Pediatric Hypertension	1.00	5/1/2011	University of North Carolina - Chapel Hill (PEDS)	information
Pharmacologic Management of Pediatric Acute Pain	1.00	9/29/2011	University of North Carolina - Chapel Hill (PEDS)	information
Pharmacologic Management of Pediatric Juvenile Idiopathic Arthritis	1.00	5/1/2011	University of North Carolina - Chapel Hill (PEDS)	information

** This activity has been planned and implemented in accordance with the Essential Areas & Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Texas Southwestern Medical Center and the Federation of State Medical Board Foundation. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

CME Modules from PharmedOut (Georgetown University Medical Center)
The following modules from PharmedOut (Georgetown University Medical Center) are currently available:

Pharmalyzer: Are you prescribing under the influence? enables prescribers to assess their individual susceptibility to pharmaceutical marketing (3.0 CME credits).
- View with CME
- Download pdf Only
Drug Approval in the US: How Drugs get to Market provides a brief history of the FDA and describes the process by which new drugs are approved (1.0 CME credit).

Generic Drugs: Prescribing Sensibly describes how generic drugs are approved, and how they compare to branded drugs (1.0 CME credit).

* This activity has been planned and implemented in accordance with the Essential Areas & Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Texas Southwestern Medical Center and the Federation of State Medical Boards Foundation. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.